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1. Introduction
  Pregnancy associated with diabetes including diabetes 
before pregnancy and gestational diabetes mellitus (GDM) 
is one of the most common obstetrics complications. GDM 
refers to abnormal glycometabolism detected at the first 
time during pregnancy, which considered as one type of 
diabetes by WHO from 1979 would pose a health risk for 
mother or babies. Insulin resistance and insulin secretion 
defection play an important role in the pathogenesis of 
GDM. Among related genes, adiponectin (APN) gene is of 
special concern. Clinical practice found that Chinese herb 
extracts ophiopogon-polysaccharide could lower blood 
glucose. Here we aimed to investigate the relationship 
of ophiopogon-polysaccharide on APN in adipose and 
placenta tissue of gestational diabetic mellitus rat.
2. Materials and methods
2.1. Animals 
  
  Wistar rats (male, n=25; female, n=50) weighted 240-275 g 
were purchased directly from Animal Center of Guangdong 
Medical College, and housed in an experimental room under 
controlled conditions of air change rate (8-12 times/h),
temperature (20依2)℃, humidity (55依5)%, noise (below 85 
decibels), ammonia concentration (20 ppm), and a 12-hour 
light/dark cycle with ad libitum access to standard chow 
and tap water. The bedding was changed and the animals’ 
were recorded weight every day. After adaptability breeding 
for 1 week, rats were kept from eating for 12 h then the 
animal weight was recorded, and fasting plasma glucose 
was measured with blood obtained via tail prick The 
animals with fasting plasma glucose≥11.1 mmol/L were 
excluded. The male rats cohabited with female in estrus for 
one night, and 50 pregnant rats were obtained. Pregnant rats 
were assigned randomly into five groups: normal pregnancy 
group, GDM group, ophiopogon-polysaccharide 125 mg/kg 
group, 250 mg/kg group, 500 mg/kg group. After pregnancy, 
diabetes was induced by way of a single subcutaneous 
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injection of 2% streptozotocin (STZ) at a dosage of 45 mg/kg. 
Normal pregnancy animals received a single subcutaneous 
injection of citrate buffer. Diabetes was defined as a blood 
glucose concentration ≥11.1 mmol/L, or urine glucose ≥2+.
2.2. Treatments 
  For diabetic rats receiving ophiopogon-polysaccharide 
group 125 mg/kg, group 250 mg/kg, group 500 mg/kg, 
treatment was initiated from day 4 after STZ injection. 
Normal pregnancy group and GDM group rats received 
equivalent normal saline.
2.3. Reagent and instrument  
  STZ (Sigma, USA), citric acid (KeyGEN, Nanjing, China.) 
ophiopogon-polysaccharide (Rsbio, Shanghai, China), rat-
specific ELISA kit for adiponectin, (Puwei, Beijing China.), 
TRIzol Reagent (invitrogen) primer synthesis (Rsbio, 
Shanghai, China), RT-PCR kit (TAKATA), I group 125 Insulin 
Antibody Radioimmunoassay Kit (Qingdao aohai biology co., 
LTD. China).
2.4. Method
  Blood glucose was measured after 12 h fasting, using 
glucose oxidase (GOD) method with blood obtained via tail 
prick. The serum was stored in -20 ℃ refrigerator after 3 000 rpm,
4℃ centrifuging 10 min for measurement.  
  Serum insulin was measured after 12 h fasting, using I 
group 125 insulin antibody radioimmunoassay kit with blood 
obtained via tail prick. The serum was stored in -20 ℃ 
refrigerator after 3 000 rpm, 4 ℃ centrifuging 10 min for 
measurement.
  Adiponectin in serum placental tissue were analyzed 
using a commercially available ELISA kit, The OD ratio was 
analyzed using Curve Exert 1.3 software.
  The adipose tissue and placental were collected at 14 days 
after pregnant. The tissue were immediately frozen and 
stored at -80 ℃ refrigerator measurement. APN-mRNA in 
adipose tissue and placenta Total RNA from adipose tissue 
or placenta was isolated with Trizol after grinding in liquid 
nitrogen. Two microliter RNA was used as a template for 
Reverse transcription. The total volume of was 20 毺L. cDNA 
was synthetized at 37 ℃ for 20 min, then 80 ℃ for 10 sec.
Two microliter product was used as a template for PCR 
amplification The primer was as follows: APN primers: P1-
APN: 5’-GGT GCA CCC TTA GGA CCA AGA-3’ P2-APN: 
5’-AAA CTT GTG CAG GTT GGA TG-3’, 80 bp; 毬-actin 
primers: P1-毬-actin:5’-AAC AGT CCG CCT AGA AGC AT-
3’,P2-毬-actin: 5’-AGC AGA TGT GGA TCA GC AAG-3’, 95 bp.
The target gene was semi-quantitative analyzed by using 毬
-actin as internal standard control.
2.5. Statistical analysis 
  All measurement data are presented as mean依SE. The 
difference between means was analyzed using t-test. All 
statistical analyses were performed using SPSS 13.0 software. 
P values <0.05 were considered statistically significant. 
The difference between count data was analyzed by linear 
correlation analysis, P values <0.05 were considered 
statistically significant.
3. Result
3.1. Change of blood glucose before and after pregnancy
  Blood glucose was significantly increased on the 7th and 
14th day comparing with that before pregnancy in GDM 
group and three treatment groups (P<0.05). And the level 
was significantly lower in three treatment groups on 7th 
day and 14th day comparing with GDM group (P<0.05). And 
the decrease was more significant as the dosage increasing 
(Table 1).
3.2. Change of serum insulin before and after pregnancy
  Serum insulin was significantly increased after pregnancy 
comparing with that before pregnancy in GDM group 
and three treatment groups (P<0.05). And the level was 
significantly lower in three groups comparing with GDM 
group (P<0.05). And the decrease was more significant as the 
dosage increasing (Table 2).
3.3. Change of adiponectin in 5 groups
  The level of adiponectin was significantly decreased 
in GDM group [(5.31依0.29) 毺g/mL] comparing with 
Table 1
Change of the blood glucose in 5 groups.
Groups Before pregnancy Day 7 Day 14
Normal pregnancy group 5.27依0.74     5.93依1.34    6.21依1.27
GDM group 5.31依0.82    19.79依2.83a   24.96依3.51a
Ophiopogon-polysaccharide group  125 mg/kg 5.46依0.22      15.87依2.58a b     12.21依1.37a b 
Ophiopogon-polysaccharide group  250 mg/kg 5.09依0.59      13.36依2.07a b     11.03依0.96a b
Ophiopogon-polysaccharide group  500 mg/kg 5.40依0.83      11.75依3.64a b       9.27依3.67a b
a: P<0.05 comparing with that before pregnancy; b: P<0.05 comparing with GDM group.
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normal pregnancy group [(13.87依0.94) 毺g/mL] (P<0.05). 
After treatment, the level was significantly increased
[(7.42依0.85) 毺g/mL, (9.98依1.04) 毺g/mL, (11.37依1.28) 毺g/mL 
in tree treatment group, respectively] (P<0.05).
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Figure 1. Change of APN mRNA in adipose tissue and placenta.
1 normal pregnancy group;
2 GDM group;
3 ophiopogon-polysaccharide 125 mg/kg;
4 ophiopogon-polysaccharide 250 mg/kg;
5 ophiopogon-polysaccharide 500 mg/kg.
  The level of APN mRNA was significantly decreased in 
GDM group comparing with normal pregnancy group in 
adipose tissue and placenta (P<0.05). After treatment, the 
level was significantly increased in tree treatment group 
(P<0.05) (Figure 1).
4. Discussion
  The pathogenetic mechanism of GDM is traditionally 
attributed to insulin resistance which is due to the effects of 
prolactin, progestogen, and placental hormones. But recently 
research shows that other factors such as apiponectin may 
be concerned. Adiponectin, which is secreted by mature 
adipocyte, have a significant anti-atherosclerotic effect, 
and play an important role in glycometabolism and insulin 
sensitivity[1]. The low level of adiponectin in GDM patient 
indicates that the change of adiponectin maybe related to 
the development and progression of GDM[2]. Our study shows 
that the adiponectin level in GDM rats was significantly 
lower than normal rats, meanwhile the adiponectin mRNA 
in adipose tissue and placenta were also significantly 
reduced. Adiponectin gene which is located in type 2 
diabetes, metabolic syndrome susceptibility loci on human 
chromosome 3q2 7, is genetic associated. It is composed of 
the low molecular weight trimer, median molecular weight 
hexamer, high molecular weight isoform. It contains three 
exons and two introns about 17 kb[3,4]. Most researchers 
found that adiponectin gene polymorphism is associated 
with type 2 diabetes and insulin resistance[5]. Li et al[6] found 
that susceptibility allele to type 2 diabetes in Chinese Han 
population may be SNP +11377C, SNP +4522T, SNP +45G. 
Siitonen et al[7] found that the increased incidence of type 
2 diabetes is related to +3317 allele. Some study found that 
adiponectin SNP +45 was correlated with the incidence of 
gestational diabetes and the decrease of adiponectin level[8-
11]. Some study also shows that the adiponectin genes +45 
T> G and-11377C> G was related with the development of 
gestational diabetes but have no effect on body mass index 
in pregnant women with gestational diabetes[12].
  Ophiopogon polysaccharide was extracted from Ophiopogon 
japonicus (Thunb.) Ker-Gawl dried roots. It contains a 
variety of saponins, such as ophiopogon A, B, B ‘, C, C ‘, 
D, D’, and high level of flavonoid compounds: Ophiopogon 
flavone A, B, methyl radix ophiopogonis flavonoids 
A, B, ophiogonanone A, B, methylophiopogonanone, 
6-aldehydoisoophiopogonanone and 6-aldehydo-
isoophipogonone A, B. It also contains volatile oil, 
phytosterol, monosaccharide and oligosaccharides. 
Pharmacological experiments show that it plays an important 
role in cardiovascular system, and can enhance myocardial 
contraction and protecte myocardial ischemia. But large 
doses ophiopogon polysaccharide can inhibit myocardial 
contractility, reduce coronary blood flow. It also has sedative, 
hypnotic, anticonvulsant effect, regulates the immune 
system, and anti-aging[13]. Our study found that the blood 
glucose in ophiopogon polysaccharide treatment groups is 
significantly lower than GDM group, while adiponectin in 
serum, adipose tissue and placenta is significantly higher. 
It indicate that ophiopogon polysaccharide has a good 
therapeutic effect on animal models of gestational diabetes.
Our study only explored the change of adiponectin in serum, 
adipose tissue, and placenta after treated with ophiopogon-
polysaccharide in animal models. The mechanism of 
Table 2 
Change of serum insulin in 5 groups (MIU/L).
Groups Before pregnancy After pregnancy
Normal pregnancy group 11.36依0.25 11.84依1.34
GDM group 11.28依0.43  40.69依5.57a
Ophiopogon-polysaccharide group  125 mg/kg 11.09依0.36    35.87依4.78 a b
Ophiopogon-polysaccharide group  250 mg/kg 11.47依0.81    30.42依5.07 a b 
Ophiopogon-polysaccharide group  500 mg/kg 11.51依0.73    27.49依6.95 a b
a: P<0.05 comparing with that before pregnancy; b: P<0.05 comparing with GDM group.
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ophiopogon-polysaccharide is not involved. Our further 
study will discuss more about the mechanism and the 
relationship between gestational diabetes and adiponectin 
gene polymorphism.
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